The Neonatal Detection of Cystic Fibrosis by Measurement of Immunoreactive Trypsin in Blood

Boat TF Welsh MJ Beaudet AL . Cystic fibrosis. In: Scriver CL Beaudet AL Sly WS Valle D . (eds). The Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 1989.

Quinton PM . Chloride impermeability in cystic fibrosis. Nature (London) 1983; 301: 421–22.

Schoumacher RA Shoemaker RL Halm DR Tallant EA Wallace RW Frizzell RA . Phosphorylation fails to activate chloride channels from cystic fibrosis airway cells. Nature (London) 1987; 330: 752–54.

Hwang T-C Lu L Zeitlin PL Gruenert DC Huganir R Guggino WB . Chloride channels in CF: Lack of activation by protein kinase C and cAMP-dependent protein kinase. Science 1989; 244: 1351–53.

Landry DW Akabas MH Redhead C Edelman A Cragoe EJ Al-Awqati Q. Purification and reconstitution of chloride channels from kidney and trachea. Science 1989; 244: 1469–72.

Rommens JM Ianuzzi MC Kerem B-S Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 1989; 245: 1059–65.

Riordan JR Rommens JM Kerem B-S Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 1989; 245: 1066–73.

Ringe D Petsko GA . Cystic fibrosis—a transport problem? Nature 1990; 346: 312–13.

Kerem B-S Rommens JM Buchanan JA Identification of the cystic fibrosis gene: Genetic analysis. Science 1989; 245: 1073–80.

Stewart AD . Screening for cystic fibrosis (letter). Nature 1989; 341: 696.

Schwachman H Redmond A Khaw K-T. Report of 130 patients diagnosed under 3 months of age over a 20-year period. Pediatrics 1970; 46: 335–43.

Orenstein DM Boat TF Stern RC The effect of early diagnosis and treatment in cystic fibrosis: A seven-year study of 16 sibling pairs. Am J Dis Child 1977; 131: 973–75.

George L Norman AP . Life tables for cystic fibrosis. Arch Dis Child 1971; 46: 139–43.

Wilcken B Towns SJ Mellis CM . Diagnostic delay in cystic fibrosis: Lessons from newborn screening. Arch Dis Child 1983; 58: 863–6.

Wilcken B Chalmers G. Reduced morbidity in patients with cystic fibrosis detected by neonatal screening. Lancet 1985; ii: 1319–21.

Kuzemko JA . Neonatal screening for cystic fibrosis (letter). Lancet 1986; i: 327–8.

Taussig LM Boat TF Dayton D Neonatal screening for cystic fibrosis: Position paper. Pediatrics 1983; 72: 741–5.

Phelan PD . Screening for cystic fibrosis. In: Meadow R . (ed). Recent Advances in Paediatrics: Vol VII. Edinburgh: Churchill Livingstone, 1984.

Phelan PD . Screening for cystic fibrosis (commentary). Arch Dis Child 1982; 57: 779–80.

Gibson LE . Screening of newborns for cystic fibrosis (marginal comments). Am J Dis Child 1980; 134: 925–92.

Heeley AF Watson D. Cystic fibrosis—its biochemical detection. Clin Chem 1983; 29: 2011–18.

Dodge JA Ryley HC . Screening for cystic fibrosis. Arch Dis Child 1982; 57: 774–80.

Crossley JR Elliott RB Smith PA . Dried-blood spot screening for cystic fibrosis in the newborn. Lancet 1979; i: 472–4.

Largman C Brodrick JW Geokas MC . Radioimmunoassay determination of circulating pancreatic endopeptidases. Methods in Enzymology 1981; 74: 272–90.

Levine JJ Udall JN Jr Block KJ . Plasma immunoreactive trypsin(ogen) levels during development. J Paediatr Gastrenterol Nutr 1988; 7: 406–10.

Borgstrom A Ohlsson K. Studies on the turnover of endogenous cathodal trypsinogen in man. Eur J Clin Invest 1978; 8: 379–82.

Brodrick JW Largman C Geokas MC O'Rourke M Ray SB . Clearance of circulating anionic and cationic pancreatic trypsinogens in the rat. Am J Physiol 1980; 239: G511–15.

Oppenheimer EH Esterly JR . Cystic fibrosis of the pancreas. Arch Pathol Lab Med 1973; 96: 149–54.

Imrie JR Fagan DG Sturgess JM . Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants. Am J Pathol 1979; 95: 697–708.

Kopelman H Durie P Gaskin K Weizman Z Forstner G. Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis. N Engl J Med 1985; 312: 329–34.

Lucas A. Hormones, nutrition and the gut. In: Tanner MS Stocks RJ . (eds). Neonatal Gastroenterology: Contemporary Issues. Newcastle upon Tyne: Intercept Books Ltd, 1984.

Folsch UR Cantor P Wilms HM Schafmayer A Becker HD Creutzfeld W. Role of CCK in the negative feedback control of pancreatic enzyme secretion. Gastroenterology 1987; 92: 449–58.

Guy-Crotte O Amourie M Figarella C. Characterization and N-terminal sequence of a degradation product of 14,000 molecular weight isolated from human pancreatic juice. Biochem Biophys Res Commun 1984; 125: 516–23.

Temler RS Felber JP . Radioimmunoassay of human plasma trypsin. Biochim Biophys Acta 1976; 445: 720–8.

Geokas MC Largman C Brodrick JW Johnson JH . Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay. Am J Physiol 1979; 236: E77–83.

Largman C Brodrick JW Geokas MC Johnson JH . Demonstration of human pancreatic anionic trypsinogen in normal serum by radioimmunoassay. Biochem Biophys Acta 1978 543: 450–4.

Mallory PA Travis J. Human pancreatic enzymes. Biochemistry 1973; 12: 2847–51.

Borgstrom A Ohlsson K. Radioimmunological determination and characterization of cathodal trypsin-like immunoreactivity in normal human plasma. Scand J Clin Lab Invest 1976; 36: 809–14.

Florholmen J Jorde R Ohlsen RL Kolmannskog S Burhol PG . Radioimmunoassay of cationic trypsin-like immunoreactivity in man. Scand J Gastroenterol 1984; 19: 613–21.

Crossley JR Smith PA Edgar BW Gluckman PD Elliott RB . Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spots. Clin Chim Acta 1981; 113: 111–21.

Malvano R Marchisio M Massaglia A Radioimmunoassay of trypsin-like substances in human serum. Scand J Gastroenterol 1980; 15 (Suppl 62): 3–10.

Elias E Redshaw M Wood T. Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin. Lancet 1977; ii: 66–8.

Adrian TE Besterman HS Mallinson CN Plasma trypsin in chronic pancreatitis and pancreatic adenocarcinoma. Clin Chim Acta 1979; 97: 205–12.

Travis J Roberts RC . Human trypsin. Biochemistry 1969; 8: 2884–9.

Adrian TE . Plasma trypsin-like immunoreactivity in normal subjects and in patients with pancreatic diseases. Scand J Gastroenterol 1980; 15 (Suppl 62): 15–20.

Feinstein G Hofstein R Koifmann J Sokolovsky M. Human pancreatic proteolytic enzymes and protein inhibitors. Eur J Biochem 1974; 43: 569–81.

Wood TP Redshaw MR . Units for immunoreactive trypsin. Lancet 1979; i: 781–2.

Niemann E , RIA-gnost® Trypsin—a kit for the radioimmunoassay of trypsin in the blood of neonates. Mucoviscidose Depistage Neonatal et Prise en Change Precoce. Proceedings of Conference, Caen, France 1988: 91–109.

Bowling FG Watson ARA Rylatt DB Elliott JE Bunch RJ Bundesen PG . Monoclonal antibody-based enzyme immunoassay for trypsinogen in neonatal screening for cystic fibrosis. Lancet 1987; i: 826–27.

Cabrini G Pederzini F Perobelli L Mastella G. An evaluation of an enzyme-immunoassay method for immunoreactive trypsin in dried blood spots. Clin Biochem 1990; 23: 1–7.

Petterson K Soderholm J Suonpää M. Optimisation of an immunofluorometric assay based on the Delfia® technique for the measurement of immunoreactive trypsin in dry blood spots. In: Proceedings of the 4th International Conference on Newborn Screening for Cystic Fibrosis. Pediatr Pulmonol 1991; 7 (Suppl).

King DN Heeley AF Walsh MP Kuzemko JA . Sensitive trypsin assay for dried-blood specimens as a screening procedure for early detection of cystic fibrosis. Lancet 1979; ii: 1217–19.

Applegarth DA Davidson AGF Kirby LT Dried blood spot screening for cystic fibrosis (letter). Lancet 1979; ii: 1236–7.

Kirby LT Applegarth DA Davidson AGF Wong LTK Hardwick DF . Use of a dried blood spot in immunoreactive trypsin assay for detection of cystic fibrosis in infants. Clin Chem 1981; 27: 678–80.

Ryley HC Robinson PG Yamashiro Y Bradley DM . Assay of serum immunoreactive trypsin in dried blood spots and the early detection of cystic fibrosis. J Clin Pathol 1981; 34: 90–1.

Borgstrom A Sveger T Lindberg T Kollberg H Larsson A. Immunoreactive trypsin screening for cystic fibrosis. Acta Paediatr Scand 1982; 71: 621–4.

Heeley AF Heeley ME King DN Kuzemko JA Walsh MP . Screening for cystic fibrosis by dried blood spot trypsin assay. Arch Dis Child 1982; 57: 18–21.

Wilcken B Brown ARD Urwin R Brown DA . Cystic fibrosis screening by dried blood spot trypsin assay: Results in 75,000 newborn infants. J Pediatr 1983; 102: 383–7.

Kirby LT Davidson AFG Applegarth DA Wong LTK Hardwick DF . Conclusions from a pilot immunoreactive trypsin newborn screen for cystic fibrosis (Letter). Clin Chem 1983; 29: 1559–60.

Dauphinais RM Ganeshananthan M Jezyk P. Dried blood spot screening of newborns for cystic fibrosis. J Clin Immunoassay 1986; 9: 37–41.

Adriaenssens K Janssens H Van Soom H. Two tier screen for cystic fibrosis. Lancet 1981; i: 833.

Bowling FG Brown ARD . Newborn screening for cystic fibrosis using an enzyme linked immunoabsorbant assay (ELISA) technique. Clin Chim Acta 1988; 171: 257–62.

Carrere J Estevenon JP Guy-Crotte O Thouvenot JP Figarella C. Physiologically elevated concentrations of serum trypsin-like immunoreactivity in newborns. Biol Neonate 1986; 49: 113–20.

Heeley AF Heeley ME Richmond SWJ . The value of blood trypsin measurement by RIA in the early diagnosis of cystic fibrosis. In: Albertini A Crosignani PG . (eds). Progress in Perinatal Medicine: Vol I. Biochemical and Biophysical Procedures. Amsterdam: Elsevier, 1983: 195–203.

Wilcken B. An evaluation of screening for cystic fibrosis. In: Buchwald M O'Riordan J . (eds). Genetic and Epithelial Cell Dysfunction in Cystic Fibrosis. New York: Alan R Liss, 1987.

Travert G. Cystic fibrosis screening in the newborn. Medical Laboratory 1986; 14: 17–22.

Travert G Mustin C Fernandez Y. Dosage radioimmologique de la trypsine dans le sang seche. Nouv Press Med 1981; 10: 2093–5.

Bowling F Cleghorn G Chester A Neonatal screening for cystic fibrosis. Arch Dis Child 1988; 63: 196–8.

Ryley HC Deam SM Williams J Neonatal screening for cystic fibrosis in Wales and the West Midlands: Evaluation of immunoreactive trypsin test. J Clin Pathol 1988; 41: 726–9.

Roberts G Stanfield M Black A Redmond A. Screening for cystic fibrosis: A four year regional experience. Arch Dis Child 1988; 63: 1438–43.

Wesley AW Smith PA Elliott RB . Experience with neonatal screening for cystic fibrosis in New Zealand using measurement of immunoreactive trypsinogen. Aust Paediatr J 1989; 25: 151–5.

Hammond KB Abman SH Sokol RJ Accurso FJ . Efficacy of statewide newborn screening for cystic fibrosis based on persistent elevation of trypsinogen. New Engl J Med 1991; 325: 769–74.

Heeley ME Travert G Ferre C Lemonnier F. The International Quality Assurance Program for the assay of immunoreactive trypsin in dried blood spots. In: Proceedings of 4th International Conference on Newborn Screening for Cystic Fibrosis. Pediatr Pulmonol 1991 (Suppl 7).

Pederzini F Armani P Barlocco EG Comparison of meconium and spot trypsin tests for CF neonatal screening. In: Lawson D . (ed). Cystic Fibrosis Horizons. Chichester: J Wiley 1984: 213.

Barlocco EG Benetazzo D Borgo G Historical course of neonatal screening for cystic fibrosis in Veneto and surrounding areas. In: Kuzemko JA Joint GS . (eds). Insights into Paediatrics: Clinical Implications of Screening for Cystic Fibrosis in the Newborn. Macclesfield: Gardiner-Caldwell Communications, 1987: 6–12.

Hammond KB Ask CG Watts DC . Neonatal screening for cystic fibrosis in Colorado.’ In: Kuzemko JA Joint GS . (eds). Insights into Paediatrics: Clinical Implications of Screening for Cystic Fibrosis in the Newborn. Macclesfield: Gardiner-Caldwell Communications, 1987: 35–43.

Bourguignon JP Deby-Dupont G Reuter A Senterre J Gerard A Franchimont P. Variations in dried blood spot immunoreactive trypsin in relation to gestational age during the first week of life. Eur J Pediatr 1986; 144: 547–9.

Travert G Laroche D Duhamel JF Blandin C. Age related IRT blood levels and incidence of trypsin binding IgG in CF and normal children. In: Lawson D . (ed). Cystic Fibrosis: Horizons. Chichester: J Wiley, 1984: 207.

Rock MJ Mischler EH Farrell PM Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels. Pediatrics 1990; 85: 1001–7.

Heeley ME Addison GM . Factors affecting the stability and homogeneity of IRT in dried blood spots. In: Travert G . (ed). Conference Proceedings: Mucoviscidose. Depistage Neonatal et Prise en Charge Precoce. Universite de Caen, France, 1988: 229.

Laroche D Jezequel M Travert G. Trypsin binding immunoglobulin G in cystic fibrosis, allergic and normal children. J Pediatr Gastroenterol Nutr 1986; 5: 404–7.

Wilcken B Towns SJ Mellis CM . Diagnostic delay in cystic fibrosis: Lessons from newborn screening. Arch Dis Child 1983; 58: 863–6.

Waters DL Dorney SFA Gaskin KJ . Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening programme. New Engl J Med 1990; 322: 303–8.

Wilcken B Brown A. An analysis of false negative screening tests for cystic fibrosis. In: Travert G . (ed). Conference Proceedings: Mucoviscidose. Depistage Neonatal et Prise en Charge Precoce. Universite de Caen, France, 1988: 69–80.

Pederzini F Armani P Faraguna D Non-CF neonatal hypertrypsinaemia. In: Kuzemko JA Joint GS . (eds). Insights into Pediatrics: Clinical Implications of Screening for Cystic Fibrosis in the Newborn. Macclesfield: Gardiner-Caldwell Communications, 1987: 19–20.

Travert G Laroche D Duhamel JF Denis A Pasquet C Blandin C. Neonatal screening for cystic fibrosis in Normandy. In: Kuzemko JA Joint GS . (eds). Insights into Pediatrics: Clinical Implications of Screening for Cystic Fibrosis in the Newborn. Macclesfield: Gardiner-Caldwell Communications, 1987.

Heeley AF Fagan DG . Trisomy 18, cystic fibrosis and blood immunoreactive trypsin. Lancet 1984; i: 169–70.

Moller-Petersen J Pedersen S. Cathodic TLI in serum. Influence of sex, age, renal function, food and diurnal variation. Clin Chim Acta 1982; 124: 31–7.

Duhamel JF Travert G Delmas P Brouard J Venezia R. Special features of the time related evolution in IRT blood levels, in six newborns with cystic fibrosis complicated by meconium ileus. In: Lawson D . (ed). Cystic Fibrosis: Horizons. Chichester: J Wiley, 1984: 280.

Heeley AF Heeley ME . Biochemical screening of the neonatal population for the early detection of cystic fibrosis in E. Anglia 1980–86. In: Kuzemko JA Joint GS . (eds). Insights into Paediatrics: Clinical Implications of Screening for Cystic Fibrosis in the Newborn. Macclesfield: Gardiner-Caldwell Communications, 1987: 49–58.

Heeley ME Keenan CA Heeley AF . An update of cystic fibrosis screening in E. Anglia 1980–89. In: Proceedings 4th International Conference on Newborn Screening for Cystic Fibrosis. Pediatr Pulmonol 1991 (Suppl 7).

Durie PR Forstner GG Gaskin KJ Age-related alterations of immunoreactive pancreatic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Paediatr Res 1986; 20: 209–13.

Greer RM Oxborough D Bowling FG Longitudinal study of pancreatic disease and nutritional status in CF patients diagnosed by neonatal screening. In: Proceedings of the 10th International Cystic Fibrosis Congress. Excerpta Medica Asia, Hong Kong 1988: 22.

Accurso FJ Abman SH Reardon MC Sokol RJ Hammond KB . Early abnormalities in growth, nutritional status and fat absorption in infants with cystic fibrosis diagnosed through newborn screening. In: Proceedings of the 10th International Cystic Fibrosis Congress. Excerpta Medica Asia, Hong Kong 1988: 23.

Waters DL Dorney SFA Gaskin KJ Gruca MA O'Halloran M Wilcken B. Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening programme. New Engl J Med 1990; 322: 303–8.

Chatfield S Owen G Ryley HC Neonatal screening for cystic fibrosis in Wales and the West Midlands: Clinical assessment after five years of screening. Arch Dis Child 1991; 66: 29–33.

Littlewood JM Kelleher J Rawson I Comprehensive assessment of patients at a CF centre identifies suboptimal treatment and improves management, symptoms and conditions. In: Proceedings of 10th International Cystic Fibrosis Congress. Excerpta Medica Asia, Hong Kong 1988: 89–90.

Dankert-Roelse JE de Meerman GJ Martijn A ten Kate LP Knol K. Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screening. J Paediatr 1989; 114: 362–7.

Mastella G Barlocco EG Antonacci B Is neonatal screening for cystic fibrosis advantageous? In: Travert G . (ed). Conference Proceedings: Mucoviscidose. Depistage Neonatal et Prise en Charge Precoce. Universite de Caen, France, 1988: 127–43.

Barlocco EG Borgo G Braggion C Influence of genetic screening and medical care on the course of cystic fibrosis. In: Proceedings of 10th International Cystic Fibrosis Congress. Excerpta Medica Asia, Hong Kong. 1988: 26–7.

Green MR Nicholson K Heeley AF Prospective study of CF in infants identified by screening: Natural history and assessment of intervention. In: Proceedings of 4th N American and 1990 International Cystic Fibrosis Conference. Pediatr Pulmonol 1990 (Suppl 5): 245–6.

Frankenburg WK . Selection of diseases and tests in pediatric screening. Pediatrics 1974; 54: 612–16.

Hammond KB Reardon MC Accurso FJ . Neonatal screening and early diagnosis of cystic fibrosis. Virginia: National Technical Information Service, 1988.

Dauphinois R. Comparative costs in diagnosing cystic fibrosis by blood-spot screening vs non-screening. In: Proceedings of 4th International Conference on Newborn Screening for Cystic Fibrosis. Pediatr Pulmonol 1991 (Suppl 7).

Wilfond BS Fost N. The cystic fibrosis gene, medical and social implications of heterozygote detection. JAMA 1990; 263: 2777–83.

Cystic Fibrosis. Closing the gap. Lancet 1990; 336: 539–40.

Bowling FG McGill JJ Shepherd RW Danks DM . Screening for cystic fibrosis: Use of ΔF₅₀₈ mutation. Lancet 1990; 335: 925–6.

Larouche D Travert G. Abnormal frequency of ΔF₅₀₈ mutation in neonatal transitory hypertrypsinaemia. Lancet 1991; i: 55.

Ranieri E Ryall RG Morris P Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis. BMJ 1991; 302: 1237–40.

Laroche D Peres O Lemonnier BF Vers une nouvelle strategie de depistage neonatal de la mucoviscidose. Arch Fr Pediatr 1990; 47: 251–3.

Zach MS . Pathogenesis and management of lung disease in cystic fibrosis. J R Soc Med 1991; 84 (Suppl 18): 10–17.

Various authors in: Proceedings of 4th N American and 1990 International Conference. Pediatr Pulmonol 1990 (Suppl 5).